Anthropic has launched an AI product aimed at scientists and pharmaceutical groups, as the $900bn company seeks to expand its enterprise business and boost revenues ahead of its planned initial public offering.
The San Francisco-based start-up announced Claude Science on Tuesday, its first product dedicated to scientists, with use cases including rendering 3D protein structures and drug discovery.
“We believe that the greatest opportunity to have a scaled positive impact on humanity is through our work in the sciences and in particular in life sciences and healthcare,” Eric Kauderer-Abrams, head of life sciences at Anthropic, said in an interview.
您已阅读14%（653字），剩余86%（3877字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。